Morgan Stanley raised the firm’s price target on Phibro Animal Health (PAHC) to $45 from $34 and keeps an Equal Weight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAHC:
- Phibro Animal Health price target raised to $50 from $45 at JPMorgan
- Phibro Animal Health Reports Strong Q1 Growth
- Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth
- Phibro Animal Health reports Q1 EPS 73c, consensus 60c
- Phibro Animal Health sees FY26 EPS $2.64-$2.81, consensus $2.63